BioLife Solutions, Inc. (BLFS) vs Palvella Therapeutics, Inc. (PVLA)
A side-by-side comparison of BioLife Solutions, Inc. and Palvella Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BLFS
BioLife Solutions, Inc.
$38.61HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
PVLA
Palvella Therapeutics, Inc.
$128.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BLFS vs PVLA
growth of $100 · dividends reinvested · last 2yBLFS +53.3% (+23.8%/yr)PVLA +677.4% (+178.8%/yr)PVLA compounded faster over this window
Log scale — wide-divergence pair
BLFS PVLA
BLFS vs PVLA: by the numbers
- •BLFS is the larger company ($1.89B vs $1.84B market cap).
- •BLFS is profitable (49.06% net margin) while PVLA runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | BLFS | PVLA |
|---|---|---|
| P/E ratio | 37.72 | N/A |
| Forward P/E | 64.35 | N/A |
| P/S ratio | 18.35 | N/A |
| P/B ratio | 4.49 | 8.47 |
| EV / EBITDA | 170.26 | N/A |
Profitability
| Metric | BLFS | PVLA |
|---|---|---|
| Gross margin | 64.48% | 0.00% |
| Operating margin | -1.12% | 0.00% |
| Net margin | 49.06% | 0.00% |
| ROE | 12.01% | -28.45% |
| ROIC | 1.72% | -23.90% |
Growth (annualized)
| Metric | BLFS | PVLA |
|---|---|---|
| Revenue CAGR (5Y) | 6.78% | N/A |
| Total return CAGR (5Y) | -0.77% | N/A |
Frequently asked
- Is BLFS or PVLA more profitable?
- BLFS runs the higher net margin — BLFS at 49.06% versus PVLA at 0.00%.
Go deeper
Dig into the metrics
BioLife Solutions P/E ratioBioLife Solutions ROEPalvella Therapeutics ROEBioLife Solutions operating marginPalvella Therapeutics operating marginBioLife Solutions revenue growthPalvella Therapeutics revenue growthBioLife Solutions free cash flowPalvella Therapeutics free cash flow
BioLife Solutions & Palvella Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.